Based on our study, a GLP-1 receptor agonist-based weight-loss program appears to be superior to non-GLP-1 receptor agonist-based weight-loss programs and intensive lifestyle modification alone for treating post-bariatric surgery weight regain, regardless of surgery type, the researchers wrote
Knee osteoarthritis therapy: recent advances in intra-articular drug delivery systems
Risks and Side Effects of IGF-1 LR3 While IGF-1 LR3 is generally well-tolerated, some individuals may experience mild side effects, such as muscle soreness, fluid retention, hypoglycemia, or insulin resistance
Europe Glucagon-like Peptide-1 (GLP-1) Agonists Market Trends The market is witnessing several trends and developments to improve the current scenario
Immunomodulation and anti-inflammatory effects of garlic compounds
doi:10.1152/ajpheart.00486.2019 Graham DL, Madkour HS, Noble BL, Schatschneider C, Stanwood GD